Tellus Therapeutics wins Early Stage Company Shootout

Posted by on Dec 4, 2018 in Newsroom | 0 comments

An A-list group of investors and companies attended the 20th Anniversary Southeast BIO Investor & Partnering Forum (SEBIO) on November 13-14th at the Loews Hotel in Atlanta. The Forum is the Southeast’s only regional life sciences venture capital conference. As always, one of the most popular parts of the conference is the Early Stage Shootout. The Early Stage Shootout focuses on best practices for newly emerging companies. Sixteen early stage opportunities were selected by a committee of venture capital investors led by Peter Young of Pappas Capital. These companies then pitched...

Read More

NC companies shine at SEBIO Forum

Posted by on Nov 29, 2018 in Newsroom | 0 comments

Bioscience companies from North Carolina dominated the awards competition at the 20th annual SEBIO Investor and Partnering Forum in Atlanta this month, with nine Tar Heel firms earning recognition. Of the five awards given for best-in-class deals in 2018, four went to North Carolina companies: Locus Biosciences of Raleigh won for best initial venture funding. It raised $19 million in Series A financing to develop precision antimicrobials for drug-resistant bacterial infections. Precision BioSciences of Durham won for best venture funding after securing $110 million in Series B financing....

Read More

SEBIO Recap of the 20th Anniversary Forum

Posted by on Nov 29, 2018 in Newsroom, SEBIO News | 0 comments

An A-list group of investors and companies attended the 20th Anniversary Southeast BIO Investor & Partnering Forum (SEBIO) on November 13-14th at the Loews Hotel in Atlanta. The Forum is the Southeast’s only regional life sciences venture capital conference. “The success of this year’s Forum is a testament to SEBIO’s significant role in connecting investment capital from up and down the eastern U.S. with the most promising biomedical companies for our seven-state region,” said Todd Sherer, Chair of SEBIO and Emory University Interim Vice President of...

Read More

Mednax launching AI incubator for radiology innovation

Posted by on Nov 29, 2018 in Newsroom | 0 comments

SUNRISE, FL. – Mednax announced Tuesday it is launching an artificial intelligence incubator aimed at developing innovative radiology products. Mednax, which manages physician practices nationwide including radiology, said its MDR-AI Incubator will bring together radiologists and technology partners to stimulate product development with the goal of “improving radiologists’ accuracy and efficiency and overall quality of patient care.” The incubator will be headquartered in Sunrise, with work split between Florida and Minnesota, the company said. It will include both startup...

Read More

Brammer Bio is Named Manufacturing Company of the Year

Posted by on Nov 29, 2018 in Newsroom | 0 comments

ALACHUA, FL. – Brammer Bio (“Brammer”), a best-in-class cell and gene therapy contract development and manufacturing organization (CDMO), was recognized by the Greater Gainesville Chamber of Commerce as the Manufacturing Company of the Year at its recent 2018 Business of the Year awards program. Brammer was also named one of the top-three finalists for the BioScience Company of the Year award. The Greater GainesvilleChamber of Commerce’s mission is to facilitate economic opportunity, business success and community progress.  The awards assess these factors, as...

Read More

Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix Inc.

Posted by on Nov 29, 2018 in Newsroom | 0 comments

MIRAMAR, FL. – Generex Biotechnology Corporation (OTC:GNBT) announced today the signing of a Letter of Intent to acquire 51 percent of Olaregen Therapeutix Inc., a New York-based regenerative medicine company. Generex made an initial payment of $400,000 on November 27, 2018 to secure the agreement, and the company is in the process of completing the legal documents with a plan to close the transaction in the coming weeks. Olaregen will introduce its first product, Excellagen®, a flowable dermal matrix that is a 510K FDA cleared medical device for utilization for a variety of...

Read More